Andreas Michael Schmitt

15PUBLICATIONS
149CO-AUTHORS
Language documentation and descriptionApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 10, 2026
Data Extraction From Oncology Imaging Reports by Large Language Models: A Comparative Accuracy Study.

|Jul 10, 2026
10-Years of First-Line Ipilimumab and Nivolumab in Advanced Melanoma: A Single Centre Experience.

|Dec 11, 2024
Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours.

Ignacio Melero, Maria de Miguel Luken, Guillermo de Velasco

|Oct 07, 2024
Dual Immune Checkpoint Inhibition in Melanoma and PD-L1 Expression: The Jury Is Still Out.

Andreas Michael Schmitt, James Larkin, Sapna P Patel

|Mar 13, 2024
Anatomic versus non-anatomic liver resection for hepatocellular carcinoma-A European multicentre cohort study in cirrhotic and non-cirrhotic patients.

Jasmin Zeindler, Gabriel Fridolin Hess, Maximilian von Heesen

|Mar 28, 2023
Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways.

Lavinia Spain, Alexander Coulton, Irene Lobon

Pageof 3

Frequent Collaborators

4 joint publications

Lars G Hemkens

4 joint publications

John P A Ioannidis

4 joint publications

David Moher

3 joint publications

Sherief Abd-Elsalam